Terns Pharmaceuticals Inc (TERN)
5.905
-0.24
(-3.83%)
USD |
NASDAQ |
May 17, 16:00
5.905
0.00 (0.00%)
After-Hours: 20:00
Terns Pharmaceuticals Cash from Operations (TTM): -75.81M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -75.81M |
December 31, 2023 | -67.39M |
September 30, 2023 | -59.28M |
June 30, 2023 | -52.02M |
March 31, 2023 | -50.19M |
December 31, 2022 | -49.11M |
September 30, 2022 | -48.57M |
Date | Value |
---|---|
June 30, 2022 | -43.21M |
March 31, 2022 | -40.81M |
December 31, 2021 | -41.83M |
September 30, 2021 | -38.54M |
June 30, 2021 | -36.78M |
March 31, 2021 | -36.84M |
December 31, 2020 | -29.81M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-75.81M
Minimum
Mar 2024
-29.81M
Maximum
Dec 2020
-47.87M
Average
-45.89M
Median
Cash from Operations (TTM) Benchmarks
Viking Therapeutics Inc | -54.87M |
Eli Lilly and Co | 3.676B |
Pfizer Inc | 8.578B |
Amgen Inc | 8.096B |
Madrigal Pharmaceuticals Inc | -389.32M |